JP Stock MarketDetailed Quotes
4536 Santen Pharmaceutical
- 1686.5
- +16.0+0.96%
20min DelayTrading Nov 25 11:30 JST
613.92BMarket Cap23.30P/E (Static)
1697.5High1681.5Low393.50KVolume1689.5Open1670.5Pre Close664.00MTurnover1878.552wk High0.12%Turnover Ratio364.02MShares1315.552wk Low73.19EPS TTM549.55BFloat Cap2234.0Historical High23.30P/E (Static)325.85MShs Float196.4Historical Low72.37EPS LYR0.96%Amplitude34.00Dividend TTM2.04P/B100Lot Size2.02%Div YieldTTM
Santen Pharmaceutical Key Stats
EPS
According to the latest financial report of Santen Pharmaceutical, the latest earnings per share (TTM) for the company is 29.50. Investing in companies with strong earnings per share can potentially provide higher returns.
Currency: JPY
Quarterly
Loading...
FCF
Interested in knowing about Santen Pharmaceutical's free cash flow? The latest report shows it as 11.12B. Keep an eye on and closely monitor the company's cash flow to make informed investment decisions.
Currency: JPY
Quarterly
Loading...
Current Ratio
If you are evaluating a company's liquidity, current ratio is an important measure to consider. The latest financial report of Santen Pharmaceutical shows that the company's current ratio is 2.61, indicating healthy liquidity.
Currency: JPY
Quarterly
Loading...
Quick Ratio
Another liquidity indicator to closely monitor is quick ratio. According to the latest financial results of Santen Pharmaceutical, the quick ratio is 1.87, indicating that the company can meet its short-term debt obligations.
Currency: JPY
Quarterly
Loading...
ROE
Want to learn more about the financial health of Santen Pharmaceutical? The latest ROE figure is 0.01%, indicating that the company has stable profitability.
Currency: JPY
Quarterly
Loading...
ROA
Investors looking for profitability indicators may be interested in ROA. According to the latest financial results of Santen Pharmaceutical, the total asset return on investment (ROA) is 0.01%.
Currency: JPY
Quarterly
Loading...
Gross Margin
Gross margin can provide insight into a company's pricing strategy and cost structure. Check Santen Pharmaceutical's latest financial report to see how their gross margin is doing - currently at 57.20%.
Currency: JPY
Quarterly
Loading...
Net Margin
For investors focusing on operational efficiency, net profit margin is an important indicator. According to the latest financial results of Santen Pharmaceutical, the net profit margin is 14.19%, which is a good sign for its profitability.
Currency: JPY
Quarterly
Loading...
Analysis
Price Target
No Data
Heat List
JP
Overall
Symbol
Latest Price
% Chg
No Data